Clinical outcome after resection arthroplasty in RegJoint© implantation of the fourth and/or fifth tarsometatarsal joint

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032783

Enrollment

Registered

2023-11-21

Start date

2023-01-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the fourth and fifth tarsometatarsal joints

Interventions

Group 1: Patients who underwent resection arthroplasty with implantation of a Reg-Joint implant in the fourth and/or fifth tarsometatarsal joint at Diakovere Annastift in Hanover between April 1, 2021

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Implantation of a Reg-Joint implant in the fourth and/ or fifth tarsometatarsal joint in the Diakovere Annastift in the period from 01.04.2014 to 31.12.2022 (minimum follow-up 1 year).

Exclusion criteria

Exclusion criteria: - Patients under 18 - Wheelchair-bound - Simultaneous joint stiffening surgery proximal to the NC joint row

Design outcomes

Primary

Measure	Time frame
Preoperative and postoperative EFAS score results differed significantly.	—

Secondary

Measure	Time frame
- Recording and evaluation of further clinical scores pre- and postoperatively - Recording of revision and complication rates - Recording and evaluation of analgesic requirements pre- and postoperatively - Recording and evaluation of the period of the reintegration phase and the period until "return to sports"	—

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift

yvonne.noll@diakovere.de+49 511 5354 649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026